One-Third of European Patients with Axial Spondyloarthritis Reach Pain Remission With Routine Care Tumor Necrosis Factor Inhibitor Treatment

Lykke Midtbøll Ørnbjerg*, Kathrine Rugbjerg, Stylianos Georgiadis, Simon Horskjær, Lykke Midtbøll Ørnbjerg, Kathrine Rugbjerg, Stylianos Georgiadis, Simon Horskjær Rasmussen, Ulf Lindström, Karel Pavelka, Neslihan Yilmaz, Ennio Giulio Favalli, Michael J Nissen, Brigitte Michelsen, Elsa Vieira-Sousa, Gareth T Jones, Ruxandra Ionescu, Heikki Relas, Carlos Sanchez-Piedra, Matija TomšičArni Jon Geirsson, Irene van der Horst-Bruinsma, Johan Askling, Anne Gitte Loft, Lucie Nekvindova, Haner Direskeneli, Florenzo Iannone, Karen Minde Fagerli, Maria José Santos, Gary J Macfarlane, Catalin Codreanu, Kari Eklund, Manuel Pombo-Suarez, Ziga Rotar, Bjorn Gudbjornsson, Tamara Rusman, Mikkel Østergaard, Merete Lund Hetland

*Corresponding author af dette arbejde

Fingeraftryk

Dyk ned i forskningsemnerne om 'One-Third of European Patients with Axial Spondyloarthritis Reach Pain Remission With Routine Care Tumor Necrosis Factor Inhibitor Treatment'. Sammen danner de et unikt fingeraftryk.

Medicin og biovidenskab